Rovaldi Christopher 4
4 · ACCELERON PHARMA INC · Filed Apr 4, 2018
Insider Transaction Report
Form 4
Rovaldi Christopher
SVP, Program Mgmt and Ops
Transactions
- Sale
Common Stock
2018-04-03$39.02/sh−600$23,412→ 25,858 total - Sale
Common Stock
2018-04-03$38.27/sh−2,900$110,983→ 26,458 total
Footnotes (4)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.78 to $38.63 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- [F3]Includes 594 shares acquired pursuant to the Acceleron Pharma Inc. Employee Stock Purchase Plan on March 15, 2018.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.80 to $39.20 inclusive. The reporting person undertakes to provide Acceleron Pharma Inc., any security holder of Acceleron Pharma Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.